Korean researchers develop ultra-precise CRISPR technique that dramatically improves detection of rare cancer mutations
Researchers have engineered a highly accurate CRISPR variant that removes normal DNA before sequencing, enabling detection of circulating tumour DNA at levels as low as 0.005%. The MUTE-Seq method showed promising results in early-stage lung and pancreatic cancer patients, where conventional liquid biopsy often fails.


